Top Key Companies for Comparator Drug Sourcing Market: AmerisourceBergen Corporation, Avantor, Inc., Catalent, Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group, MCKESSON CORPORATION, Myonex, PHARMA’S ALMANAC, Sharp Services, LLC, Thermo Fisher Scientific, TransCelerate BioPharma Inc..
Global Comparator Drug Sourcing Market Size was estimated at USD 1556.6 million in 2022 and is projected to reach USD 2567.76 million by 2028, exhibiting a CAGR of 8.7% during the forecast period.
Global Comparator Drug Sourcing Market Overview And Scope:
The Global Comparator Drug Sourcing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Comparator Drug Sourcing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Comparator Drug Sourcing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Comparator Drug Sourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Comparator Drug Sourcing market.
Global Comparator Drug Sourcing Market Segmentation
By Type, Comparator Drug Sourcing market has been segmented into:
Local Sourcing
Central Sourcing
By Application, Comparator Drug Sourcing market has been segmented into:
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
Regional Analysis of Comparator Drug Sourcing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Comparator Drug Sourcing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Comparator Drug Sourcing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Comparator Drug Sourcing market.
Top Key Companies Covered in Comparator Drug Sourcing market are:
AmerisourceBergen Corporation
Avantor
Inc.
Catalent
Clinical Services International (CSI)
Clinigen Clinical Supplies Management
Intertek Group
MCKESSON CORPORATION
Myonex
PHARMA’S ALMANAC
Sharp Services
LLC
Thermo Fisher Scientific
TransCelerate BioPharma Inc.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Comparator Drug Sourcing Market by Type
5.1 Comparator Drug Sourcing Market Overview Snapshot and Growth Engine
5.2 Comparator Drug Sourcing Market Overview
5.3 Local Sourcing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Local Sourcing: Geographic Segmentation
5.4 Central Sourcing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Central Sourcing: Geographic Segmentation
Chapter 6: Comparator Drug Sourcing Market by Application
6.1 Comparator Drug Sourcing Market Overview Snapshot and Growth Engine
6.2 Comparator Drug Sourcing Market Overview
6.3 Drug Producers/Manufacturers
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Drug Producers/Manufacturers: Geographic Segmentation
6.4 CMO
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 CMO: Geographic Segmentation
6.5 Academic and Research Institute
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Academic and Research Institute: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Comparator Drug Sourcing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Comparator Drug Sourcing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Comparator Drug Sourcing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 AMERISOURCEBERGEN CORPORATION
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 AVANTOR
7.4 INC.
7.5 CATALENT
7.6 CLINICAL SERVICES INTERNATIONAL (CSI)
7.7 CLINIGEN CLINICAL SUPPLIES MANAGEMENT
7.8 INTERTEK GROUP
7.9 MCKESSON CORPORATION
7.10 MYONEX
7.11 PHARMA’S ALMANAC
7.12 SHARP SERVICES
7.13 LLC
7.14 THERMO FISHER SCIENTIFIC
7.15 TRANSCELERATE BIOPHARMA INC.
Chapter 8: Global Comparator Drug Sourcing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Local Sourcing
8.2.2 Central Sourcing
8.3 Historic and Forecasted Market Size By Application
8.3.1 Drug Producers/Manufacturers
8.3.2 CMO
8.3.3 Academic and Research Institute
8.3.4 Others
Chapter 9: North America Comparator Drug Sourcing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Local Sourcing
9.4.2 Central Sourcing
9.5 Historic and Forecasted Market Size By Application
9.5.1 Drug Producers/Manufacturers
9.5.2 CMO
9.5.3 Academic and Research Institute
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Comparator Drug Sourcing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Local Sourcing
10.4.2 Central Sourcing
10.5 Historic and Forecasted Market Size By Application
10.5.1 Drug Producers/Manufacturers
10.5.2 CMO
10.5.3 Academic and Research Institute
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Comparator Drug Sourcing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Local Sourcing
11.4.2 Central Sourcing
11.5 Historic and Forecasted Market Size By Application
11.5.1 Drug Producers/Manufacturers
11.5.2 CMO
11.5.3 Academic and Research Institute
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Comparator Drug Sourcing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Local Sourcing
12.4.2 Central Sourcing
12.5 Historic and Forecasted Market Size By Application
12.5.1 Drug Producers/Manufacturers
12.5.2 CMO
12.5.3 Academic and Research Institute
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Comparator Drug Sourcing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Local Sourcing
13.4.2 Central Sourcing
13.5 Historic and Forecasted Market Size By Application
13.5.1 Drug Producers/Manufacturers
13.5.2 CMO
13.5.3 Academic and Research Institute
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Comparator Drug Sourcing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Local Sourcing
14.4.2 Central Sourcing
14.5 Historic and Forecasted Market Size By Application
14.5.1 Drug Producers/Manufacturers
14.5.2 CMO
14.5.3 Academic and Research Institute
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Comparator Drug Sourcing Scope:
|
Report Data
|
Comparator Drug Sourcing Market
|
|
Comparator Drug Sourcing Market Size in 2025
|
USD XX million
|
|
Comparator Drug Sourcing CAGR 2025 - 2032
|
XX%
|
|
Comparator Drug Sourcing Base Year
|
2024
|
|
Comparator Drug Sourcing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
AmerisourceBergen Corporation, Avantor, Inc., Catalent, Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group, MCKESSON CORPORATION, Myonex, PHARMA’S ALMANAC, Sharp Services, LLC, Thermo Fisher Scientific, TransCelerate BioPharma Inc..
|
|
Key Segments
|
By Type
Local Sourcing
Central Sourcing
By Applications
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
|
